Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2K Buy
31
+4
+15% +$1.37K 0.01% 216
2026
Q1
$9.5K Hold
27
0.01% 252
2025
Q4
$8.84K Hold
27
0.01% 254
2025
Q3
$8.84K Hold
27
0.01% 254
2025
Q2
$7.54K Hold
27
0.01% 238
2025
Q1
$8.41K Hold
27
0.01% 212
2024
Q4
$7.04K Buy
+27
New +$8.01K 0.01% 203

Other funds holding AMGN

Clark Wealth Partners's AMGN Position: Q2 2026 in Review

Clark Wealth Partners increased its Amgen (AMGN) stake by 15% in Q2 2026, buying an estimated $1.37K and bringing the position to 31 shares worth $11.2K. The position accounts for 0.01% of the portfolio, ranked #216.

Clark Wealth Partners first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,029 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Clark Wealth Partners held 31 shares of Amgen worth $11.2K as of Q2 2026.
  • Clark Wealth Partners bought 4 Amgen shares in Q2 2026, an estimated $1.37K.
  • Amgen made up 0.01% of Clark Wealth Partners's portfolio in Q2 2026, its #216 holding.
  • Clark Wealth Partners first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,029 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.